Central Trust Co

SEC CIK: 0000044365
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Central Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 6,641
Value: $3.30M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of VRTX by Central Trust Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	6,641	$3.30M	0.1%	−322−4.6%	Reduced	Holders
Q1 2026	6,963	$3.11M	0.1%	−400−5.4%	Reduced	Holders
Q4 2025	7,363	$3.34M	0.1%	−1,030−12.3%	Reduced	Holders
Q3 2025	8,393	$3.29M	0.1%	−623−6.9%	Reduced	Holders
Q2 2025	9,016	$4.01M	0.1%	+31+0.3%	Added	Holders
Q1 2025	8,985	$4.36M	0.1%	−806−8.2%	Reduced	Holders
Q4 2024	9,791	$3.94M	0.1%	−196−2.0%	Reduced	Holders
Q3 2024	9,987	$4.64M	0.1%	−80−0.8%	Reduced	Holders
Q2 2024	10,067	$4.72M	0.1%	−108−1.1%	Reduced	Holders
Q1 2024	10,175	$4.25M	0.1%	−274−2.6%	Reduced	Holders
Q4 2023	10,449	$4.25M	0.1%	+115+1.1%	Added	Holders
Q3 2023	10,334	$3.59M	0.1%	+319+3.2%	Added	Holders
Q2 2023	10,015	$3.52M	0.1%	+634+6.8%	Added	Holders
Q1 2023	9,381	$2.96M	0.1%	−390−4.0%	Reduced	Holders
Q4 2022	9,771	$2.82M	0.1%	−1,269−11.5%	Reduced	Holders
Q3 2022	11,040	$3.20M	0.1%	−893−7.5%	Reduced	Holders
Q2 2022	11,933	$3.36M	0.1%	+753+6.7%	Added	Holders
Q1 2022	11,180	$2.92M	0.1%	−280−2.4%	Reduced	Holders
Q4 2021	11,460	$2.52M	0.1%	−3,000−20.7%	Reduced	Holders
Q3 2021	14,460	$2.62M	0.1%	−2,036−12.3%	Reduced	Holders
Q2 2021	16,496	$3.33M	0.1%	−1,844−10.1%	Reduced	Holders
Q1 2021	18,340	$3.94M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.